1. Home
  2. ESP vs SKYE Comparison

ESP vs SKYE Comparison

Compare ESP & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Espey Mfg. & Electronics Corp.

ESP

Espey Mfg. & Electronics Corp.

HOLD

Current Price

$47.00

Market Cap

148.8M

Sector

Technology

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.87

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESP
SKYE
Founded
1928
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
148.8M
44.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ESP
SKYE
Price
$47.00
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.75
AVG Volume (30 Days)
14.9K
494.0K
Earning Date
02-11-2026
11-10-2025
Dividend Yield
2.13%
N/A
EPS Growth
28.72
N/A
EPS
3.16
N/A
Revenue
$42,600,530.00
N/A
Revenue This Year
$9.16
N/A
Revenue Next Year
$5.68
N/A
P/E Ratio
$14.83
N/A
Revenue Growth
4.90
N/A
52 Week Low
$24.85
$0.68
52 Week High
$55.00
$5.75

Technical Indicators

Market Signals
Indicator
ESP
SKYE
Relative Strength Index (RSI) 66.01 38.82
Support Level $46.27 $0.68
Resistance Level $47.77 $0.95
Average True Range (ATR) 1.37 0.11
MACD 0.19 -0.00
Stochastic Oscillator 81.68 38.81

Price Performance

Historical Comparison
ESP
SKYE

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: